IBDEI1CI ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21745,1,3,0)
 ;;=3^Eosinophilic Pneumonia,Chronic
 ;;^UTILITY(U,$J,358.3,21745,1,4,0)
 ;;=4^J82.81
 ;;^UTILITY(U,$J,358.3,21745,2)
 ;;=^24374
 ;;^UTILITY(U,$J,358.3,21746,0)
 ;;=J82.82^^70^925^7
 ;;^UTILITY(U,$J,358.3,21746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21746,1,3,0)
 ;;=3^Eosinophilic Pneumonia,Acute
 ;;^UTILITY(U,$J,358.3,21746,1,4,0)
 ;;=4^J82.82
 ;;^UTILITY(U,$J,358.3,21746,2)
 ;;=^5159205
 ;;^UTILITY(U,$J,358.3,21747,0)
 ;;=J82.83^^70^925^6
 ;;^UTILITY(U,$J,358.3,21747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21747,1,3,0)
 ;;=3^Eosinophilic Asthma
 ;;^UTILITY(U,$J,358.3,21747,1,4,0)
 ;;=4^J82.83
 ;;^UTILITY(U,$J,358.3,21747,2)
 ;;=^5159206
 ;;^UTILITY(U,$J,358.3,21748,0)
 ;;=G89.22^^70^926^2
 ;;^UTILITY(U,$J,358.3,21748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21748,1,3,0)
 ;;=3^Chr Post-Thoracotomy Pain
 ;;^UTILITY(U,$J,358.3,21748,1,4,0)
 ;;=4^G89.22
 ;;^UTILITY(U,$J,358.3,21748,2)
 ;;=^5004156
 ;;^UTILITY(U,$J,358.3,21749,0)
 ;;=G89.3^^70^926^4
 ;;^UTILITY(U,$J,358.3,21749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21749,1,3,0)
 ;;=3^Neoplasm Related Pain
 ;;^UTILITY(U,$J,358.3,21749,1,4,0)
 ;;=4^G89.3
 ;;^UTILITY(U,$J,358.3,21749,2)
 ;;=^5004159
 ;;^UTILITY(U,$J,358.3,21750,0)
 ;;=G89.18^^70^926^1
 ;;^UTILITY(U,$J,358.3,21750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21750,1,3,0)
 ;;=3^Acute Postprocedural Pain
 ;;^UTILITY(U,$J,358.3,21750,1,4,0)
 ;;=4^G89.18
 ;;^UTILITY(U,$J,358.3,21750,2)
 ;;=^5004154
 ;;^UTILITY(U,$J,358.3,21751,0)
 ;;=G89.29^^70^926^3
 ;;^UTILITY(U,$J,358.3,21751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21751,1,3,0)
 ;;=3^Chronic Pain
 ;;^UTILITY(U,$J,358.3,21751,1,4,0)
 ;;=4^G89.29
 ;;^UTILITY(U,$J,358.3,21751,2)
 ;;=^5004158
 ;;^UTILITY(U,$J,358.3,21752,0)
 ;;=J94.1^^70^927^1
 ;;^UTILITY(U,$J,358.3,21752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21752,1,3,0)
 ;;=3^Fibrothorax
 ;;^UTILITY(U,$J,358.3,21752,1,4,0)
 ;;=4^J94.1
 ;;^UTILITY(U,$J,358.3,21752,2)
 ;;=^5008317
 ;;^UTILITY(U,$J,358.3,21753,0)
 ;;=C45.0^^70^927^2
 ;;^UTILITY(U,$J,358.3,21753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21753,1,3,0)
 ;;=3^Pleura Mesothelioma
 ;;^UTILITY(U,$J,358.3,21753,1,4,0)
 ;;=4^C45.0
 ;;^UTILITY(U,$J,358.3,21753,2)
 ;;=^5001095
 ;;^UTILITY(U,$J,358.3,21754,0)
 ;;=J94.8^^70^927^4
 ;;^UTILITY(U,$J,358.3,21754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21754,1,3,0)
 ;;=3^Pleural Conditions NEC
 ;;^UTILITY(U,$J,358.3,21754,1,4,0)
 ;;=4^J94.8
 ;;^UTILITY(U,$J,358.3,21754,2)
 ;;=^5008319
 ;;^UTILITY(U,$J,358.3,21755,0)
 ;;=J94.9^^70^927^3
 ;;^UTILITY(U,$J,358.3,21755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21755,1,3,0)
 ;;=3^Pleural Condition,Unspec
 ;;^UTILITY(U,$J,358.3,21755,1,4,0)
 ;;=4^J94.9
 ;;^UTILITY(U,$J,358.3,21755,2)
 ;;=^5008320
 ;;^UTILITY(U,$J,358.3,21756,0)
 ;;=J91.8^^70^927^6
 ;;^UTILITY(U,$J,358.3,21756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21756,1,3,0)
 ;;=3^Pleural Effusion in Conditions Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,21756,1,4,0)
 ;;=4^J91.8
 ;;^UTILITY(U,$J,358.3,21756,2)
 ;;=^5008311
 ;;^UTILITY(U,$J,358.3,21757,0)
 ;;=J90.^^70^927^5
 ;;^UTILITY(U,$J,358.3,21757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21757,1,3,0)
 ;;=3^Pleural Effusion NEC
 ;;^UTILITY(U,$J,358.3,21757,1,4,0)
 ;;=4^J90.
 ;;^UTILITY(U,$J,358.3,21757,2)
 ;;=^5008310
 ;;^UTILITY(U,$J,358.3,21758,0)
 ;;=J92.0^^70^927^7
